After an FDA roundtable raised alarms about antidepressant use in pregnancy, physicians warn the rhetoric could fuel fear, stigma, and dangerous gaps in care.
In a first-of-its-kind RCT, early testosterone access led to an 11.6-point improvement in self-rated health scores among transgender and gender-diverse adults, while delayed-treatment controls showed no significant change.